Fundz

Evaxion Appoints Dr Helen Tayton-Martin as Chief Executive Officer

PRIVATEOct 27, 2025

Position

Chief Executive Officer

Company

Evaxion

Helen Tayton-Martin
HørsholmBiotechnologyHealth CareArtificial Intelligence

Description

Evaxion A/S has appointed Dr Helen Tayton-Martin as the new CEO, effective November 24, 2025. Dr Tayton-Martin brings extensive experience in biotech and cancer immunotherapy, making her well-suited to lead the company's strategic initiatives.

Quick answer

Evaxion Appoints Dr Helen Tayton-Martin as Chief Executive Officer (October 27, 2025). Evaxion is based in Hørsholm, Capital Region of Denmark, Denmark.

Who is the new Chief Executive Officer at Evaxion?
Evaxion named Helen Tayton-Martin Chief Executive Officer, announced October 27, 2025.
What did Evaxion announce on October 27, 2025?
Evaxion A/S has appointed Dr Helen Tayton-Martin as the new CEO, effective November 24, 2025. Dr Tayton-Martin brings extensive experience in biotech and cancer immunotherapy, making her well-suited to lead the company's strategic initiatives.
What does Evaxion do?
Evaxion A/S is a clinical-stage TechBio company based in Copenhagen, Denmark.
Where is Evaxion based?
Evaxion is based in Hørsholm, Capital Region of Denmark, Denmark.
Which similar companies made leadership changes around the same time?
Montai Therapeutics (October 28, 2025), Algorae Pharmaceuticals (October 15, 2025), ImpriMed (October 14, 2025) and Fifty1 AI Labs (October 9, 2025) also announced leadership changes within 45 days of Evaxion.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Evaxion, and when

A new leader at Evaxion brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Evaxion raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evaxion, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evaxion. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evaxion

Location

Hørsholm, Capital Region of Denmark, Denmark

About

Evaxion A/S is a clinical-stage TechBio company based in Copenhagen, Denmark. It specializes in developing AI-Immunology™ powered vaccines. The company focuses on addressing serious global medical issues through innovative vaccine candidates. Evaxion aims to harness the power of artificial intelligence to uncover novel vaccine targets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evaxion changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Evaxion's next move

Learn about Strategic plan

Evaxion changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.